Find Therapeutics is a Canadian biotechnology startup that is dedicated to designing ground-breaking therapies through precision-targeting of membrane receptors to bring hope to people living with autoimmune diseases. Launched in 2020, the company has received significant investments from CTI Life Sciences, adMare BioInnovations, Domain Therapeutics, and an exclusive global license from Strasbourg University on a technology and related know-how developed by Dr. Dominique Bagnard. The last investment was a seed round investment from CTI Life Sciences Fund in August 2020. With a focus on developing next generation therapies to treat inflammatory autoimmune diseases, Find Therapeutics is positioning itself to make a meaningful impact in the biotechnology industry. The company's slogan "Bringing hope by expanding the frontiers of therapy" underscores its commitment to innovation and making a positive difference in the lives of patients.
No recent news or press coverage available for Find Therapeutics.